Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:31 pm Sale | 2020-12-31 | 13G | Zogenix, Inc. ZGNX | PERCEPTIVE ADVISORS LLC | 0 0.000% | -3,709,152 (Position Closed) | Filing History |
| 2021-02-16 3:30 pm Purchase | 2020-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | PERCEPTIVE ADVISORS LLC | 3,693,516 7.400% | 490,110 (+15.30%) | Filing History |
| 2021-02-16 3:30 pm Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | PERCEPTIVE ADVISORS LLC | 3,493,607 6.800% | 3,493,607 (New Position) | Filing History |
| 2021-02-16 3:30 pm Unchanged | 2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | PERCEPTIVE ADVISORS LLC | 2,150,641 7.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:30 pm Purchase | 2020-12-31 | 13G | DBV Technologies S.A. DBVT | PERCEPTIVE ADVISORS LLC | 221,106 8.100% | 82,552 (+59.58%) | Filing History |
| 2021-02-08 5:16 pm Purchase | 2021-01-25 | 13D | Athira Pharma, Inc. ATHA | PERCEPTIVE ADVISORS LLC | 3,425,916 9.800% | 3,425,916 (New Position) | Filing History |
| 2021-02-08 5:15 pm Purchase | 2021-01-28 | 13D | Astria Therapeutics, Inc. ATXS | PERCEPTIVE ADVISORS LLC | 412,821 10.500% | 412,821 (New Position) | Filing History |
| 2021-02-08 09:16 am Purchase | 2021-01-28 | 13G | AnaptysBio, Inc. ANAB | PERCEPTIVE ADVISORS LLC | 1,495,336 5.500% | 1,495,336 (New Position) | Filing History |
| 2021-01-27 5:03 pm Sale | 2021-01-22 | 13G | Motus GI Holdings, Inc. MOTS | PERCEPTIVE ADVISORS LLC | 8,868 8.300% | -5,167 (-36.81%) | Filing History |
| 2021-01-27 4:35 pm Purchase | 2020-12-21 | 13G | SCYNEXIS, Inc. SCYX | PERCEPTIVE ADVISORS LLC | 1,300,000 6.800% | 1,300,000 (New Position) | Filing History |
| 2020-12-17 09:30 am Purchase | 2020-12-10 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 720,257 12.700% | 270,270 (+60.06%) | Filing History |
| 2020-12-14 08:33 am Purchase | 2020-12-04 | 13G | RAPT Therapeutics, Inc. RAPT | PERCEPTIVE ADVISORS LLC | 1,327,481 5.400% | 1,327,481 (New Position) | Filing History |
| 2020-11-24 08:02 am Purchase | 2020-11-23 | 13D | MeiraGTx Holdings plc MGTX | PERCEPTIVE ADVISORS LLC | 6,973,737 16.000% | 525,000 (+8.14%) | Filing History |
| 2020-10-28 5:01 pm Purchase | 2020-10-22 | 13G | IVERIC bio, Inc. ISEE | PERCEPTIVE ADVISORS LLC | 4,482,713 5.000% | 4,482,713 (New Position) | Filing History |
| 2020-10-28 5:00 pm Purchase | 2020-10-26 | 13G | BCLS Acquisition Corp. BLSA | PERCEPTIVE ADVISORS LLC | 1,000,000 7.000% | 1,000,000 (New Position) | Filing History |
| 2020-10-07 4:30 pm Purchase | 2020-09-29 | 13G | Coherus BioSciences, Inc. CHRS | PERCEPTIVE ADVISORS LLC | 3,586,485 5.000% | 3,586,485 (New Position) | Filing History |
| 2020-10-01 4:09 pm Purchase | 2020-09-24 | 13G | Protara Therapeutics, Inc. TARA | PERCEPTIVE ADVISORS LLC | 608,544 5.800% | 608,544 (New Position) | Filing History |
| 2020-07-13 4:30 pm Purchase | 2020-07-09 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 6,285,458 19.100% | 3,200,000 (+103.71%) | Filing History |
| 2020-06-11 5:10 pm Purchase | 2020-03-09 | 13G | MENLO THERAPEUTICS INC MNLO | PERCEPTIVE ADVISORS LLC | 22,876,410 14.000% | 22,876,410 (New Position) | Filing History |
| 2020-06-01 5:25 pm Purchase | 2020-05-05 | 13D | Lyra Therapeutics, Inc. LYRA | PERCEPTIVE ADVISORS LLC | 3,222,561 24.900% | 3,222,561 (New Position) | Filing History |